10:20 AM EST - Avivagen Inc. : Reported today its unaudited financial results for Q1 2019. For the three-month period ended January 31, 2019, the Corporation reported revenues of $322,125 – a doubling of revenues compared to revenues of $143,201 for the three-month period ended January 31, 2018 – and a comprehensive loss from continuing operations of $(1,141,797). As at January 31, 2019, the Company reported total assets of $2,118,600, total liabilities of $3,083,798 and shareholders equity of $(965,198). Avivagen Inc.
shares V.VIV are trading up $0.01 at $0.76.